ROS1 gene rearrangements are associated with an elevated risk of peri-diagnosis thromboembolic events.

Journal of Thoracic Oncology（2019）

引用 52|浏览30

暂无评分

摘要

The risk of peridiagnosis TEEs is significantly elevated in patients with advanced ROS+ NSCLC compared to EGFR+ and KRAS+ cases. TEE risk may be similarly elevated in ALK+ NSCLC.

查看译文

关键词

Lung cancer,ROS1,ALK,Oncogene driver,Thrombosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要